If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreggs Regulatory News (GRG)

Share Price Information for Greggs (GRG)

Share Price is delayed by 15 minutes
Get Live Data
1,569.00    17.00 (1.10%)
Bid:
1,568.00
Ask:
1,570.00
Spread: 2.00 (0.128%)
Market Cap: £1.60b
GRG Live PriceLast checked at - London Stock Exchange

Intraday Greggs Share Chart

Directorate Change

27 Apr 2022 07:00

RNS Number : 4419J
Greggs PLC
27 April 2022
 

 

 

 

GREGGS plc

 

Board Changes

The Board of Greggs plc announces that it has appointed Lynne Weedall as an independent non-executive director, with effect from 17 May 2022. Lynne will join the Board immediately following the close of the Annual General Meeting currently scheduled on that date.

Lynne is an experienced People and Business Transformation executive, having held senior positions most recently at Selfridges, and before that at Carphone Warehouse. Throughout her executive career Lynne has been involved in and led transformational projects in several of the companies she has worked for, which have also included Whitbread, and BUPA.

Lynne is currently the senior independent non-executive director and Remuneration Committee Chair at Dr. Martens plc, and at Stagecoach plc, and on 3 May 2022 is due to join the Board of Softcat plc as non-executive director and Chair of the Remuneration Committee. Lynne is also a non-executive director and Nominations Committee chair at Treatt plc. Lynne was previously a non-executive director and Remuneration Committee Chair of Greene King plc from 2012 until 2019 and William Hill plc from 2019 until April 2021.

The Board intends that Lynne will be appointed as Chair of the Remuneration Committee when Helena Ganczakowski steps down from the Board in 2023.

Ian Durant, Chair of Greggs, said "We are delighted that such an experienced non-executive director has accepted our invitation to join the Board. Lynne brings with her extensive experience of HR & transformational change, and will add significant value to our Board during this transitional phase and beyond".

 

Listing Rule 9.6.13R (1) to (6) Disclosure

There are no further matters required by paragraphs 9.6.13R (1) to (6) of the Listing Rules to be disclosed in relation to Lynne Weedall.

ENDS

ENQUIRIES:

 

 

Greggs plc

Hudson Sandler

Roger Whiteside, Chief Executive

Richard Hutton, Finance Director

Hattie Dreyfus / Nick Moore / Sophie Miles

Tel: 0191 281 7721

 

Tel: 020 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPURWCUPPGMQ
Date   Source Headline
27th Mar 201710:28 amRNSDirector/PDMR Shareholding
27th Mar 201710:27 amRNSDirector/PDMR Shareholding
16th Mar 201710:09 amRNSHolding(s) in Company
9th Mar 20174:58 pmRNSDirector/PDMR Shareholding
6th Mar 20173:06 pmRNSHolding(s) in Company
28th Feb 20177:00 amRNSPreliminary Results
8th Feb 20178:29 amRNSHolding(s) in Company
6th Feb 20175:28 pmRNSHolding(s) in Company
23rd Jan 20179:37 amRNSHolding(s) in Company
17th Jan 20177:00 amRNSTrading Update
21st Dec 20169:39 amRNSHolding(s) in Company
6th Dec 201610:13 amRNSBlock listing Interim Review
6th Dec 201610:10 amRNSBlock listing Interim Review
30th Nov 201610:05 amRNSDirector/PDMR Shareholding
28th Nov 20162:05 pmRNSNotice of Trading Update
2nd Nov 20164:25 pmRNSHolding(s) in Company
24th Oct 20169:56 amRNSHolding(s) in Company
17th Oct 201610:36 amRNSHolding(s) in Company
17th Oct 20169:59 amRNSHolding(s) in Company
14th Oct 20163:50 pmRNSHolding(s) in Company
4th Oct 20167:00 amRNSTrading Update
16th Sep 20163:32 pmRNSNotice of Trading Update
31st Aug 20166:12 pmRNSHolding(s) in Company
19th Aug 20167:23 amRNSHolding(s) in Company
17th Aug 201611:06 amRNSHolding(s) in Company
12th Aug 20162:56 pmRNSNotification of Transaction by PDMR
8th Aug 20167:41 amRNSHolding(s) in Company
2nd Aug 20169:56 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSInterim Results
1st Jul 20162:01 pmRNSNotice of Interim Results
29th Jun 20162:02 pmRNSChange of Director's Responsibilities
16th Jun 20169:10 amRNSBlock listing Interim Review
16th Jun 20169:09 amRNSBlock listing Interim Review
15th Jun 20167:50 amRNSAppointment of joint Corporate Broker
14th Jun 201610:12 amRNSHolding(s) in Company
8th Jun 201612:22 pmRNSHolding(s) in Company
3rd Jun 20168:18 amRNSDirector/PDMR Shareholding
2nd Jun 201610:05 amRNSDirector/PDMR Shareholding
11th May 201610:27 amRNSResult of AGM
9th May 20167:00 amRNSTrading Statement
5th May 20164:51 pmRNSHolding(s) in Company
3rd May 20163:06 pmRNSNotice of Trading Update
14th Apr 20164:23 pmRNSDirector/PDMR Shareholding
13th Apr 20169:40 amRNSNotice of AGM
6th Apr 20163:48 pmRNSDirector/PDMR Shareholding
24th Mar 20163:04 pmRNSDirector/PDMR Shareholding
24th Mar 20163:00 pmRNSDirector/PDMR Shareholding
24th Mar 20162:56 pmRNSDirector/PDMR Shareholding
24th Mar 20161:21 pmRNSDirector/PDMR Shareholding
24th Mar 20161:19 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.